Standard surgery for small renal masses (<4 cm)

Der Urologe. Ausg. A
S K FreesA Haferkamp

Abstract

Several new treatment strategies have emerged in the treatment of small renal masses (<4 cm in diameter). Active surveillance and ablative techniques have been introduced but it remains unclear which patients will benefit the most from these new treatment options. A surgical approach remains standard of care. In recent decades, radical nephrectomy has been replaced by nephron-sparing surgery for the management of small renal masses. In addition to the open partial nephrectomy, which is considered the standard approach, the number of surgeries performed using minimally invasive techniques is increasing. Recent data show that there might be some benefits such as less blood loss. The disadvantages shown by laparoscopic partial nephrectomy such as prolonged warm ischemia, longer operation times, and postoperative renal impairment might be negligible for the robotic approach. Therefore, current guidelines allow these approaches in addition to open partial nephrectomy if sufficient surgical expertise is given.

References

May 11, 1999·JAMA : the Journal of the American Medical Association·W H ChowJ F Fraumeni
Jun 19, 2007·The Journal of Urology·Inderbir S GillAndrew C Novick
Sep 12, 2007·Journal of Cancer Research and Clinical Oncology·Kan GongYanqun Na
Nov 11, 2008·The Urologic Clinics of North America·Harry W Herr
Feb 24, 2009·European Urology·Martin MarszalekStephan Madersbacher
May 20, 2009·The Journal of Urology·R Houston ThompsonPaul Russo
Dec 17, 2009·The Journal of Urology·Brian R Lane, Inderbir S Gill
Mar 20, 2010·The Journal of Urology·Sergey ShikanovArieh L Shalhav
Sep 10, 2010·European Urology·R Houston ThompsonSteven C Campbell
Oct 26, 2010·European Urology·Inderbir S GillMihir M Desai
Oct 14, 2011·BJU International·Soroush Rais-BahramiLouis R Kavoussi
May 9, 2012·Japanese Journal of Clinical Oncology·Gou KanekoMototsugu Oya
Jun 19, 2012·Current Opinion in Urology·Brian R LaneChristopher B Riedinger
Jul 31, 2012·European Urology·Steven MacLennanUNKNOWN EAU Renal Cancer Guideline Panel
Feb 7, 2013·International Urology and Nephrology·Matthew J MellonChandru Sundaram
Aug 12, 2014·World Journal of Surgical Oncology·Julie SteinestelAndres Jan Schrader
Aug 12, 2014·European Urology·R Houston ThompsonBradley C Leibovich
Apr 29, 2015·Gut and Liver·UNKNOWN Korean Liver Cancer Study Group (KLCSG), UNKNOWN National Cancer Center, Korea (NCC)
May 18, 2016·The Journal of Urology·Simon P Kim, Robert Abouassaly
Jul 21, 2017·European Urology Focus·Lorenzo MarconiHendrik Van Poppel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.